Skip to main content
Clinical Trials/CTRI/2024/07/071255
CTRI/2024/07/071255
Not yet recruiting
Phase 2

A non-randomized controlled trial to evaluate the effect of ashtamangalaghrita along with remedial therapy in the management of spelling and reading difficulty of dyslexia in children of age 7-12 years - Nil

Deepa Peethambaran0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: F810- Specific reading disorder
Sponsor
Deepa Peethambaran
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Deepa Peethambaran

Eligibility Criteria

Inclusion Criteria

  • Screened using NIMHANS Index for specific learning disabilities,IQ above 90

Exclusion Criteria

  • Children taking polytherapy for epilepsy
  • Children having visual and auditory impairments
  • Children having severe hyperactivity disorders
  • Other chronic systemic illness
  • Metabolic disorders
  • Based on clinical features and investigation reports

Outcomes

Primary Outcomes

Not specified

Similar Trials